ARTICLE | Company News
Medarex-Corixa antibody deal
June 7, 2000 7:00 AM UTC
MEDX will use its HuMAb-Mouse technology to generate human monoclonal antibodies to targets from CRXA's library of autoimmune disease, cancer, and infectious disease antigens. The project initially wi...